Stella Diagnostics, Inc. (SLDX)

Stella Diagnostics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2013	FY 2012	FY 2011	FY 2010	FY 2009
Period Ending	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Revenue	-	-	0	0.24	0.21
Revenue Growth (YoY)	-	-	-98.13%	16.21%	-
Cost of Revenue	0.01	-	-	0.1	0.01
Gross Profit	-0.01	-	0	0.14	0.19
Selling, General & Admin	0.25	0.52	0.97	1.11	0.62
Other Operating Expenses	-	-	0	0.01	0.01
Operating Expenses	0.25	0.57	1.02	1.29	0.72
Operating Income	-0.26	-0.57	-1.02	-1.14	-0.52
Other Non Operating Income (Expenses)	-0	-	-	-	-
EBT Excluding Unusual Items	-0.26	-0.57	-1.02	-1.14	-0.52
Gain (Loss) on Sale of Investments	-	-	-	-	0
Other Unusual Items	-	-0.2	0.74	-	-
Pretax Income	-0.26	-0.77	-0.28	-1.14	-0.52
Net Income	-0.26	-0.77	-0.28	-1.14	-0.52
Net Income to Common	-0.26	-0.77	-0.28	-1.14	-0.52
Shares Outstanding (Basic)	0	-	-	-	-
Shares Outstanding (Diluted)	0	-	-	-	-
EPS (Basic)	-7.53	-	-	-	-
EPS (Diluted)	-7.53	-	-	-	-
Free Cash Flow	0	-0.33	-0.52	-0.01	-0.07
Free Cash Flow Per Share	0.01	-	-	-	-
Gross Margin	-	-	100.00%	59.87%	93.48%
Operating Margin	-	-	-22599.07%	-474.40%	-252.89%
Profit Margin	-	-	-6198.84%	-474.40%	-252.54%
Free Cash Flow Margin	-	-	-11550.67%	-2.44%	-32.87%
EBITDA	-	-0.52	-0.97	-1.08	-0.44
EBITDA Margin	-	-	-	-	-210.87%
D&A For EBITDA	-	0.05	0.05	0.06	0.09
EBIT	-0.26	-0.57	-1.02	-1.14	-0.52
EBIT Margin	-	-	-	-	-252.89%
Revenue as Reported	-	-	0	0.24	-
Advertising Expenses	0.01	0.14	0	0	0

Source: S&P Global Market Intelligence. Standard template. Financial Sources.